High Expression of UBE2B as a Poor Prognosis Factor in Patients With Rectal Cancer Following Chemoradiotherapy. Huang WL, Luo CW, Chou CL, Yang CC, et al. Anticancer Res 2020;40:6305-6317.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang WL, Luo CW, Chou CL, Yang CC, et al. High Expression of UBE2B as a Poor Prognosis Factor in Patients With Rectal Cancer Following Chemoradiotherapy. Anticancer Res 2020;40:6305-6317.
PMID: 33109568